Navigation Links
Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results
Date:4/26/2011

Pacific Time, members of CTI's management team will host a conference call to discuss CTI's 2011 first quarter financial results.Conference Call NumbersWednesday, April 27, 2011 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time1-888-549-7750 (US Participants)1-480-629-9866 (International)Call-back numbers for post-listening available at 11:30 a.m. Eastern Time:1-800-406-7325 (US Participants)1-303-590-3030  (International)Passcode: 4435562#Live audio webcast at www.celltherapeutics.com will be archived for post-call listening approximately two hours after call ends.

About Cell Therapeutics, Inc.Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.CellTherapeutics.com.

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the trading price of CTI's securities. Specifically, the risks and uncertainties that could affect CTI include risks associated with preclinical and clinical developments in the biopharmaceutical industry in general, and with pixantrone in particular, including, without limitation, the potential failure of pixantrone to prove safe and effective for the treatment of relapsed or refractory aggressive NHL, relapsed or refractory DLBCL and/or other tumors (whether alone or in combination with rituximab) as determined by the FDA and/or the EMA, that if CTI conducts an additional clinical trial, it may not demonstrate the safety and effectiveness of pixantrone, that pixantrone may not be approved by the FDA or the EMA this year, the potential failure of tosedostat to prove safe and effective for
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Vista Partners Updates Coverage on Opexa Therapeutics, Inc.; Maintains Target Price of $6.50
2. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
3. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2010 Financial Results on February 16
4. Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
5. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for Pixuvri®
6. Veteran Pharmaceutical Executives Form New American Therapeutics, Inc.
7. BioMolecular Therapeutics, a New Global Player in RNAi Therapeutics, Launches Company and Adds Key Advisors
8. Precision Therapeutics, Inc. Named to Pittsburgh Business Times 2010 Top 100
9. BioMarin Acquires ZyStor Therapeutics, Inc.
10. Nonconformity of NOV002 Used in Phase 3 NSCLC Trial Sponsored by Novelos Therapeutics, Inc to NOV002 (Glutoxim(R)), Used in Phase 1/2 NSCLC and all Previous Trials
11. Reportlinker Adds The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015 Dynatronics Corporation (NASDAQ: DYNT ) today ... to the Company,s Board of Directors effective March 23, 2015, ... 2014 of board member Joseph Barton .  ... Board of Directors represents an important step forward for the ... of Dynatronics.  "Rich is a proven leader and is well-known ...
(Date:3/27/2015)... , March 27, 2015 The Temple Health & ... to a 5,000-square-foot building at 1802 South First St. in ... designated by the City of Temple ... White and the Central Texas Veterans Health Care System, the ... space to early stage biotechnology and life science companies. ...
(Date:3/27/2015)... 27, 2015 XRpro Sciences, Inc., a ... and development services which features high throughput transporter ... announced financial results for the year ended December ... Chairman of XRpro Sciences commented, "We have completed ... development stage to commercial stage in large part ...
Breaking Medicine Technology:Dynatronics Announces Appointment of Richard J. Linder to Board of Directors 2Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4
(Date:3/28/2015)... Tucson, AZ. (PRWEB) March 28, 2015 ... according to a new study by researchers ... (HSPH). , Produced with the support of the Coffee ... the journal Molecular Psychiatry this past fall, the study—one ... a meta-analysis of genomic data from more than 120,000 ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 With ... in the fields of osteoporosis, osteoarthritis and musculoskeletal ... Osteoporosis, it may be the first time in ... research forum that the hot-button topic is an ... on the well-accepted scientific principles of Wolff’s law, ...
(Date:3/28/2015)... Emergency Medical Care (EMC), a New York ... commemorated its three-year anniversary of being the only 24/7 ... 24-hour urgent care, Emergency Medical Care offers its clients ... Emergency Medical Care’s Urgent Care NYC services ... injuries, ear infections, fevers, insect bites, burns, animal bites, ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Centurion Service Group ... auction on Thursday, April 2 at their Las Vegas warehouse, ... NV 89081. The sale, which consists of equipment from hospitals ... promptly at 9 a.m. PDT. , Buyers will find ... surgery equipment. “We are a one-stop-shop,” said Erik Tivin, CEO ...
(Date:3/28/2015)... 2015 How best to treat and ... in orthopaedic medicine. While diagnostic hip injections are commonly ... pain etiology, research presented today at the American Orthopaedic ... suggests that pain relief from this diagnostic injection may ... , “Our study looked to assess if the amount ...
Breaking Medicine News(10 mins):Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2
... July 14 CyberKnife Centers of Miami and Palm,Beach ... Tampa Bay by summer,s,end. MORSE LLC of Miami, a ... the three centers in maintaining the model,of community-based outpatient ... provide the CyberKnife technology to the broadest number of,patients ...
... - Platform,s Online Content Doubled in Less Than ... scientific, technical and medical,(STM) information, today announced that ... million full-text articles., Doubling its content in ... most extensive online STM research platform. Serving the,evolving ...
... 14 Vical Incorporated,(Nasdaq: VICL ) today ... immunogenicity data from a Phase 1 trial of ... Thursday,July 17, at the IBC Life Sciences Next ... Vical,s Vice President of Vaccine Research, Larry ...
... many young,adults continue to wear slides, flip flops and ... the locker room, on campus, in,the dorm or as ... ), But, according to Dr. Leo Bronston, ... western Wisconsin and member of the American,Chiropractic Association, those ...
... hospital mobile computing solutions provider recognized by one of the ... ... Columbus, OH (PRWEB) July 14, 2008 -- Artromick ... mobile hospital computing and medical cart equipment. In today's demanding ...
... to lead a healthy ... life, ... Council of La Raza (NCLR) to unveil a small,tool aimed at battling a ... book, Buena Salud, Buena Vida --,Su Guia de Recursos de Salud, with the ...
Cached Medicine News:Health News:Elsevier's "ScienceDirect" Articles Surpass Nine-Million Mark 2Health News:Elsevier's "ScienceDirect" Articles Surpass Nine-Million Mark 3Health News:Vical to Present Phase 1 Data for Vaxfectin(R)-Formulated Pandemic Influenza DNA Vaccines 2Health News:Vical to Present Phase 1 Data for Vaxfectin(R)-Formulated Pandemic Influenza DNA Vaccines 3Health News:Choose Flip Flops Carefully for Back to School, Say Chiropractors 2Health News:Developer of Mobile Hospital Computing Equipment and Medical Carts Helps Hospital Upgrade to Wireless 2Health News:Developer of Mobile Hospital Computing Equipment and Medical Carts Helps Hospital Upgrade to Wireless 3Health News:Lilly Partners With the National Council of La Raza to Fight Chronic Disease 2Health News:Lilly Partners With the National Council of La Raza to Fight Chronic Disease 3Health News:Lilly Partners With the National Council of La Raza to Fight Chronic Disease 4
... at a very attractive price. ,The following adjustments can be ... 1/8" to 5 1/2" (98 to 135mm), Nose bridge ... adjustable 24 to 40mm on each side (48mm to 80mm ... - 120 to 0 to 135 , right - 45 ...
... offer the superior cutting advantages of ... the exclusive Rib-Back design for greater ... producer offer the wide selection of ... Every blade is packaged in a ...
BD Beaver Phaco slit blade, 3.2 mm, angled 45, bevel up. matte finish offers a precise incision which minimizes leakage during phaco procedures. Precise incision minimizes leakage during phaco proced...
BD Beaver DeBakey blade, 5 mm cutting width, sterile....
Medicine Products: